Brain

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

1 year ago

Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 30, 2025 /PRNewswire/ -- The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted…

1 year ago

Potential Revolution in Healthcare Brewing, Powered by AI Innovation

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 29, 2025 /PRNewswire/ -- USA News…

1 year ago

Brain-CA Technologies Sets New Benchmark in AI Processor Simulation with Cellular Automata Technology

CINCINNATI and SARASOTA, Fla., Jan. 29, 2025 /PRNewswire/ -- Brain-CA Technologies, a pioneer in AI innovation, has achieved a breakthrough…

1 year ago

Brain Aneurysm Foundation’s Executive Director Christine Buckley to Speak at the 2025 International Stroke Conference

HANOVER, Mass., Jan. 29, 2025 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to…

1 year ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Advancing mental health treatment through innovative research, offering insights on symptom improvement and clinical toolsMALVERN, Pa., Jan. 29, 2025 (GLOBE…

1 year ago

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan…

1 year ago

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer…

1 year ago

CervoMed to Present at the 8th International Lewy Body Dementia Conference

BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for…

1 year ago

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq:…

1 year ago